echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Endocrine System > Continuing the century-old legend of insulin with innovation, Sanofi helps diabetics get rid of the "sweet burden"

    Continuing the century-old legend of insulin with innovation, Sanofi helps diabetics get rid of the "sweet burden"

    • Last Update: 2021-04-17
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On April 10, 2021, the Sanofi Insulin Centennial Summit will be held simultaneously in 12 cities across the country through online and offline linkage.


    On April 10, 2021, the Sanofi Insulin Centennial Summit will be held simultaneously in 12 cities across the country through online and offline linkage.


    Sanofi Insulin Centennial Summit National 12-City Linkage





    Insulin sugar control of the Chinese road long way to go





    Sanofi innovation and help patients get rid of China "sweet burden"




    in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.